Calysta
Menlo Park, US · Delaware corporation · 8 known investors
Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food. The company operates in cellular agriculture and food technology, with a FeedKind production plant in China run through its Calysseo partnership.
AgTechBiotechFoodTech
Founders & leadership
AS
Alan Shaw, Ph.D.Co-founder
AS
Alan ShawPresident, Chief Executive Officer and Co-Founder
LG
Lori GiverinChief Science and Sustainability Officer
CB
Craig Barratt, Ph.D.Named on SEC filing
DH
David HayesNamed on SEC filing
SS
Suan Swee TanNamed on SEC filing
RT
Rich TorresNamed on SEC filing
Board
MV
Investors · 8
Reported raises · per SEC filings
Form D private placements$45.2M disclosed across 1 round · 2019
▶$45.2MraisedOct 2019 · 18 investors · BiotechnologyRule 506(b)
▶$45.2MraisedOct 2019 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan Shaw, Ph.D.Executive Officer, Director
- Craig Barratt, Ph.D.Director
- David HayesDirector
- Suan Swee TanDirector
- Mike VelingsDirector
- Rich TorresDirector
- Offering amount
- $120M
- Amount sold
- $45.2M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapFortis Life Sciences6 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Alcresta6 shared keywordsAlcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.
Newswise5 shared keywordsNewswise is a news distribution service that hosts and syndicates research news and press releases from universities, medical centers, and scientific organizations. It serves journalists and public information officers by aggregating expert content across fields such as science, medicine, and higher education.
Companies competing with Calysta for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Calysta do?
- Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food. The company operates in cellular agriculture and food technology, with a FeedKind production plant in China run through its Calysseo partnership.
- Who founded Calysta?
- Calysta was founded by Alan Shaw, Ph.D., Alan Shaw.
- Who are Calysta's investors?
- Calysta's investors include Aqua Spark, Baruch Future Ventures, Celesta Capital, Celesta Capital, Pangaea Ventures Us Inc., SQN Venture Partners, LLC, bp ventures, Pangaea Ventures.
- How much funding has Calysta raised?
- Calysta has disclosed $45.2M raised across 1 round.
- Where is Calysta headquartered?
- Calysta is headquartered in Menlo Park, US.